The U.S. National Comprehensive Cancer Network (NCCN) guidelines advise who should be tested for BRCA1/2 pathogenic variants in the U.S. Among the predictors for genetic counseling referral are the diagnosis of BC before the age of 50 (60 for triple-negative BC), one sole case of OC, male BC, known family history of BC, OC and/or pancreatic cancer on the same side of the family and others [7]. Here, BRCA1 is linked to breast cancer.